FOLD - Amicus Therapeutics Q3 2023 Earnings Preview
2023-11-07 11:53:49 ET
More on Amicus Therapeutics
- Amicus Therapeutics: The Right Play Now
- Amicus Therapeutics: Limited Label For Pombiliti And Opfolda And Why It May Not Matter
- Amicus: Holding Until AT-GAA U.S. Approval
- Amicus in pact with Blackstone for $430M financing
- Amicus wins FDA approval of Pompe disease treatment
For further details see:
Amicus Therapeutics Q3 2023 Earnings Preview